SARAH OLIVEIRA: Open Payments
NPI 1184235681 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$943 in 20 payments from 5 companies in 2025. Trend: 2023 $72 · 2024 $527 · 2025 $943
Food & beverage: $943
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $392 |
| BridgeBio Pharma, Inc. | 3 | $206 |
| E.R. Squibb & Sons, L.L.C. | 4 | $177 |
| PFIZER INC. | 4 | $87 |
| Novartis Pharmaceuticals Corporation | 4 | $80 |
Products named: Ozempic, Attruby, Wegovy, CAMZYOS, LEQVIO, ELIQUIS, VYNDAQEL.
Industry payments across MD — which companies pay providers there.
